GYRE THERAPEUTICS, INC. (GYRE) › Total LiabilitiesGYRE THERAPEUTICS, INC. (GYRE) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $170.94M2011: $83.84M2012: $13.66M2013: $11.26M2014: $3.46M2015: $38.10M2016: $22.02M2017: $8.74M2018: $4.97M2019: $30.22M2020: $18.78M2021: $14.57M2022: $12.54M2023: $38.06M2024: $27.00M2025: $23.85M$23.85M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$23.85M-11.7%2024$27.00M-29.1%2023$38.06M+203.6%2022$12.54M-14.0%2021$14.57M-22.4%2020$18.78M-37.9%2019$30.22M+507.4%2018$4.97M-43.1%2017$8.74M-60.3%2016$22.02M-42.2%2015$38.10M+1002.3%2014$3.46M-69.3%2013$11.26M-17.6%2012$13.66M-83.7%2011$83.84M-51.0%2010$170.94M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share